MedTrace Logo

Psychological Factors Influencing Cancer Post-traumatic Growth

NCT06278558 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 289

Last updated 2025-03-24

No results posted yet for this study

Summary

The study focuses on post-traumatic growth (positive changes linked to appreciation of life, personal strengths, social relationships...) in the context of different types of cancer and with a longitudinal approach to the care pathway. The aim of the study is to better understand whether psychological variables (emotional competence, psychological flexibility, psychological distress) and patients' care satisfaction, assessed at the start of the cancer treatment pathway, can influence their post-traumatic growth at the end of the chemotherapy protocol and 6 months later.

Conditions

Interventions

OTHER

Interviews with a psychologist/psychiatrist

All patients with a high score (≥11) on the HADS anxiety and/or depressive symptoms scale and who are not already receiving known psychological treatment or treatment mentioned in the file will be contacted by telephone by the investigator or a qualified person designated by him/her in order to conduct a telephone interview with the patient and refer him/her to a psychologist or psychiatrist if necessary. The number and percentage of consultations with a psychologist or psychiatrist following this telephone interview will be calculated in order to highlight the benefits of such a practice (HADS assessment + telephone interview with +/- referral) for earlier and easier referral. Depending on the number of patients contacted, consideration may be given to testing the effect of this approach on post-traumatic development.

Sponsors & Collaborators

  • Ligue contre le cancer, France

    collaborator OTHER

  • Centre Oscar Lambret

    collaborator OTHER

  • Centre de Cancérologie Les Dentellières

    collaborator UNKNOWN

  • Clinique Teissier

    collaborator UNKNOWN

  • Hôpital Saint Vincent de Paul, Lille

    collaborator UNKNOWN

  • Centre Hospitalier de Valenciennes

    lead NETWORK

Principal Investigators

  • Anne-Sophie Baudry · CH de Valenciennes

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-10
Primary Completion
2026-11-10
Completion
2027-11-10

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06278558 on ClinicalTrials.gov